Cell growth - PDFSEARCH.IO - Document Search Engine

Cell growth
Results: 1113

#	Item
441	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
442	Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for a Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
443	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Sponsor/Applicant/s: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
444	MSAC Application 1173: Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) testing for eligibility for erlotinib treatment as a first line therapy in patients Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Lung cancer Amines Quinazolines Organofluorides Alkynes Gefitinib Erlotinib Non-small-cell lung carcinoma Epidermal growth factor receptor Medicine Chemistry Oncology
445	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:55 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
446	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
447	MSAC Application 1161: Final Decision Analytic Protocol (DAP) to guide the assessment of testing for mutations in the epidermal growth factor receptor (EGFR) gene in patients with locally advanced or metastatic non small Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Amines Quinazolines Lung cancer Organofluorides Gefitinib Morpholines Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
448	Medical Services Advisory Committee Public Summary Document Reference No. 41 – Epidermal Growth Factor Receptor Gene Testing and Access to PBS listed Gefitinib Sponsors: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2013-11-01 01:30:18 Amines Quinazolines Tyrosine kinase receptors Lung cancer Organofluorides Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Biology
449	Public Summary Document Application No. 1293 – Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:26 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
450	Public Summary Document Application No. 1293 – Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:25 Quinazolines Organofluorides Amines Lung cancer Organochlorides Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine

UPDATE